Suven Pharmaceuticals Limited (SUVENPHAR) — Cash Flow Reinvestment Rate
Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs255.04 Million. See free cash flow generation of Suven Pharmaceuticals Limited to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suven Pharmaceuticals Limited Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Suven Pharmaceuticals Limited across 7 annual periods. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year capital reinvestment analysis for Suven Pharmaceuticals Limited. See Suven Pharmaceuticals Limited leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.43x | Rs4.11 Billion | Rs2.88 Billion | Rs1.56 Billion | ▲ +23.5% |
| 2024 | 1.15x | Rs4.14 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +8.4% |
| 2023 | 1.07x | Rs4.81 Billion | Rs4.51 Billion | Rs2.86 Billion | ▲ +168.0% |
| 2022 | 0.40x | Rs1.31 Billion | Rs3.30 Billion | Rs751.87 Million | ▼ -51.0% |
| 2021 | 0.81x | Rs3.11 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -20.4% |
| 2020 | 1.02x | Rs4.25 Billion | Rs4.16 Billion | Rs994.15 Million | ▼ -29.9% |
| 2019 | 1.46x | Rs733.40 Million | Rs504.05 Million | Rs567.86 Million | — |